Antoine Faucheron

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The mainstay treatment for patients with acute coronary syndrome is an oral route dual antiplatelet therapy with a P2Y12-receptor antagonist and Aspirin (ASA). To improve patient adherence to such treatments, combination therapies (polypill) are envisioned. Physicochemical solid-state studies have been carried out to develop a preformulation strategy of ASA(More)
  • 1